PetCaseFinder

Peer-reviewed veterinary case report

The Protective Effect of Decellularized Extracellular Matrix in Osteoarthritis: AnandStudy in Rat Model.

Journal:
In vivo (Athens, Greece)
Year:
2026
Authors:
Shin, Sakyeng & Lee, Jae Yeon
Affiliation:
Department of Companion Animal Health · South Korea
Species:
rodent

Abstract

BACKGROUND/AIM: Osteoarthritis (OA) is a degenerative joint disease affecting both humans and companion animals, characterized by progressive cartilage destruction, inflammation, and functional impairment. Current therapies provide mainly symptomatic relief, emphasizing the need for regenerative strategies. Decellularized extracellular matrix (dECM) hydrogels preserve native biochemical cues and biocompatibility, making them potential candidates for cartilage protection and regeneration. This study aimed to evaluate the biocompatibility, anti-inflammatory activity, and chondroprotective potential of meniscus-derived dECM (Meni-dECM) hydrogel. MATERIALS AND METHODS: Meniscus tissue was decellularized and processed into hydrogel form.cytocompatibility and chondrogenic potential were assessed using stem cells cultured within the hydrogel. Forevaluation, OA was induced in rats by intra-articular monosodium iodoacetate (MIA) injection. The therapeutic efficacy of intra-articularly injected Meni-dECM hydrogel was compared with control using gross joint assessment, cytokine analysis, and histological evaluation. RESULTS: assays confirmed excellent cell viability, proliferation, and upregulation of chondrogenic gene expression within the Meni-dECM hydrogel., Meni-dECM-treated rats exhibited significantly reduced joint swelling, lower serum levels of IL-1β, IL-6, and TNF-α, and improved cartilage preservation compared with control. Histological analysis revealed decreased synovial hyperplasia, reduced inflammatory infiltration, and enhanced proteoglycan retention in Meni-dECM-treated joints. CONCLUSION: Meni-dECM hydrogels demonstrated protective effects against OA progression by modulating inflammation and preserving cartilage architecture. These findings support Meni-dECM hydrogel as a promising injectable biomaterial for OA management in both veterinary and translational medicine. Further studies are warranted to confirm long-term stability, elucidate molecular mechanisms, and evaluate clinical feasibility.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication: https://pubmed.ncbi.nlm.nih.gov/41482381/